BioCryst's market cap is currently $1.50B. The company's EPS TTM is $0.06; its P/E ratio is -154.12; BioCryst is scheduled to report earnings on November 3, 2025, and the estimated EPS forecast is $0.04. See an overview of income statement, balance sheet, and cash flow financials.
